Keywords

On this page readers can obtain a listing of documents classified by keywords. Click on the bookshelf icon of a keyword to obtain the concerned documents or to return to the main list of keywords.
All - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
Expand the sub-collections menu.
74 documents on 2 pages
 
 
 
Open this document and view its content

Antiretroviral Cohort Adverse Event Monitoring In Kwazulu-Natal, April 2014

Year:

2014;

Pages:

110;


Countries:

 
Open this document and view its content

Building Clinical Trial Capacity to Develop a New Treatment for Multidrug-resistant Tuberculosis. (Bull World Health Organ 2016;94:147–152)

Year:

2016;

Pages:

6;


Regions:

 
Open this document and view its content

Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

Year:

2007;

Pages:

4;

Regions:

 
Open this document and view its content

Comprehensive Assessment of Pharmacovigilance Systems and their Performance in Sub-Saharan Africa

Year:

2012;

Pages:

1;


 
Open this document and view its content

Development of a Risk-Based Approach and Tools for Improving Safe and Rational Use of Tuberculosis Medicines

Year:

2013;

Pages:

40;


Regions:

 
Open this document and view its content

Farmacovigilancia, hacia una mayor seguridad en el uso de medicamentos - 2012

Year:

2012;

Pages:

329;


 
 
Open this document and view its content

Governance and Pharmacovigilance in Brazil: A Scoping Review

Year:

2016;

Pages:

15;

Countries:

 
Open this document and view its content

Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis

Year:

2016;

Pages:

15;

Related documents:

Countries:

 
Open this document and view its content

Implementing Active Pharmacovigilance and Cohort Event Monitoring for Multidrug-Resistant Tuberculosis Regimens in the Philippines, April 2015

Year:

2015;

Pages:

67;


Related documents:

Countries:

 
Open this document and view its content

NAFDAC Good Pharmacovigilance Practice Guidelines, 2016 - Nigeria

Year:

2016;

Pages:

180;


Related documents:

Countries:

 
Open this document and view its content

Pharmacovigilance Monitoring System - PViMS

Year:

2015;

Pages:

2;


Related documents:

Regions:

 
Open this document and view its content

Post-marketing Withdrawal of 462 Medicinal Products Because of Adverse Drug Reactions: A Systematic Review of the World Literature

Year:

2016;

Pages:

11;

Related documents:

Regions:

 
Open this document and view its content

Safety of Medicinal Products in the Philippines: Assessment of the Pharmacovigilance System and its Performance. January 2013

Year:

2013;

Pages:

68;


Related documents:

Countries:

 
Open this document and view its content

Sentinel Site–Based Pilot Active Surveillance Pharmacovigilance in the Vietnam ART Program

Year:

2010;

Pages:

39;


Countries:

 
Open this document and view its content

Standard Operating Procedures. Active Pharmacovigilance Surveillance: Drug Safety Monitoring for New Medicines and Novel Regimens of the National TB Program in the Philippines

Year:

2015;

Pages:

21;


Countries:

 
Open this document and view its content

Strengthening Research Capacity on Safety, Efficacy and Quality of Care of Traditional Medicine. Report of a Regional Expert Group Meeting, New Delhi, 11–13 December 2013

Year:

2014;

Pages:

50;


 
Open this document and view its content

Strengthening the Nevirapine Safety Signal by Using the Electronic Dispensing Tool in Namibia

Year:

2013;

Pages:

28;


Countries:

 
Open this document and view its content

WHA 16.36 - Клиническая и фармакологическая оценка фармацевтических препаратов. Всемирная ассамблея здравоохранения, 16 сессия, 1963 / WHA16.36 - Clinical and Pharmacological Evaluation of Drugs. WHA resolution; The Sixteenth World Health Assembly, 1963 [English] [French] [Spanish]

Year:

1963;

Pages:

3;


Regions:

 
Open this document and view its content

WHA17.39 - Клиническая и фармакологическая оценка лекарственных препаратов. Всемирная ассамблея здравоохранения, 17 сессия / (WHA17.39 - Clinical and Pharmacological Evaluation of Drugs. WHA resolution; The Seventeenth World Health Assembly, 1964) [English] [French] [Spanish]

Year:

1964;

Pages:

2;


Regions:

 
 
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 2, 2016